AstraZeneca adds to obesity drug race, but Eli Lilly remains in lead
"The incumbent almost always wins," Jim Cramer said this week.
Source: cnbc.com
Page 12 - Dave Ricks News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Dave Ricks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Dave Ricks Today - Breaking & Trending Today
FDA Approves Most Potent Weight Loss Drug Yet
Zepbound, made by Eli Lilly, is the newest FDA-approved drug for weight loss. (It was previously a diabetes treatment known as Mounjaro.)
Source: time.com
Eli Lilly and Company (NYSE:LLY) Q3 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q3 2023 Earnings Call. At this time all participants are in a listen-only mode [Operator Instructions].
Source: insidermonkey.com
Eli Lilly's rally on blowout Mounjaro sales signals a new leg higher for the stock
The case for owning Eli Lilly got stronger Thursday, as diabetes drug Mounjaro crossed $1 billion in quarterly sales for the first time.
Source: cnbc.com
Eli Lilly (LLY) Q3 2023 Earnings Call Transcript
LLY earnings call for the period ending September 30, 2023.
Source: fool.com